CAR T Therapy
3 stories
-
healthEuropean Cell Therapy Hits Record 1 Million Transplants
EBMT 2024 survey reports over 1 million HCTs since 1990, record allogeneic activity, and 24.5% rise in CAR T therapy across 53 countries.
-
healthCAR T Therapy Weakens Vaccine Immunity, Study Finds
New research indicates CAR T cell therapy, used for blood cancers, significantly reduces vaccine immunity against key pathogens, even with stable antibody levels.
-
healthCAR T Therapy: 4-1BB Design Dominates Leukemia Treatment
New meta-analysis reveals 4-1BB CAR T constructs offer superior efficacy and safety for relapsed B-cell acute lymphoblastic leukemia.